Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome

Neurology

Volumn 87, Issue 9, 2016, Pages S38-S45

  Pohl, Daniela ^a   Alper, Gulay ^b   Van Haren, Keith ^c,d   Kornberg, Andrew J ^e   Lucchinetti, Claudia F ^f   Tenembaum, Silvia ^g   Belman, Anita L ^h  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f MAYO CLINIC   (United States)

^g Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^h STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OLIGOCLONAL BAND;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ARTICLE; BASAL GANGLION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FOLLOW UP; GRANULOCYTE; HUMAN; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; LEUKOENCEPHALOPATHY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PLEOCYTOSIS; PRIORITY JOURNAL; WHITE MATTER LESION; BRAIN; CEREBROSPINAL FLUID; DIAGNOSTIC IMAGING; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; TREATMENT OUTCOME;

BRAIN; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HUMANS; NEUROIMAGING; TREATMENT OUTCOME;

EID: 85003451833     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002825     Document Type: Article

References (56)

1. Lucas J. An account of uncommon symptoms succeeding measles: with some additional remarks on the infection of measles and smallpox. Lond Med J 1790;11:325.
2. McAlpine D. Acute disseminated encephalomyelitis: its sequelea and its relationship to disseminated sclerosis. Lancet 1931;217:846-852.
3. Gibbons JL, Miller HG, Stanton JB. Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers. Q J Med 1956;25:427-505.
4. Absoud M, Lim MJ, Chong WK, et al. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler 2013;19:76-86.
5. Banwell B, Kennedy J, Sadovnick D, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-239.
6. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68(suppl 2):S7-S12.
7. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013;19:1261-1267.
8. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
9. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189.
10. Huppke P, Rostasy K, Karenfort M, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 2013; 19:941-946.
11. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007;11: 90-95.
12. Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344-352.
13. Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015;2:e81.
14. Ketelslegers IA, Van Pelt DE, Bryde S, et al. Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 2015;21: 1513-1520.
15. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015;86:265-272.
16. Torisu H, Kira R, Ishizaki Y, et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 2010;32:454-462.
17. Xiong CH, Yan Y, Liao Z, et al. Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: A retrospective study. BMC Public Health 2014;14:111.
18. Pohl D, Hennemuth I, von Kries R, Hanefeld F. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr 2007;166:405-412.
19. Pellegrino P, Radice S, Clementi E. Geoepidemiology of acute disseminated encephalomyelitis. Epidemiology 2014;25:928-929.
20. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 2002;59: 1224-1231.
21. Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 2014;13:215-224.
22. Young NP, Weinshenker BG, Parisi JE, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010; 133:333-348.
23. Robinson CA, Adiele RC, Tham M, Lucchinetti CF, Popescu BF. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis. Acta Neuropathol Commun 2014; 2:52.
24. Absoud M, Parslow RC, Wassmer E, et al. Severe acute disseminated encephalomyelitis: A paediatric intensive care population-based study. Mult Scler 2011;17: 1258-1261.
25. Ketelslegers IA, Visser IE, Neuteboom RF, BoonM, Catsman-Berrevoets CE, Hintzen RQ. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler 2011;17:441-448.
26. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007;68 (suppl 2):S23-S36.
27. Adamovic T, Riou EM, Bernard G, et al. Acute combined central and peripheral nervous system demyelination in children. Pediatr Neurol 2008;39:307-316.
28. Ravaglia S, Tavazzi E, Moglia A, Ceroni M, Marchioni E. Combined central and peripheral demyelination: comparison of adult and pediatric series. Pediatr Neurol 2009;41: 77-78.
29. Wassmer E, Whitehouse WP. Simultaneous peripheral and central demyelination. J Child Neurol 2008;23: 1495-1496.
30. Bernard G, Riou E, Rosenblatt B, Dilenge ME, Poulin C. Simultaneous Guillain-Barre syndrome and acute disseminated encephalomyelitis in the pediatric population. J Child Neurol 2008;23:752-757.
31. Kawamura N, Yamasaki R, Yonekawa T, et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 2013;81:714-722.
32. KimGH,KimKM, Suh SI,KiCS, Eun BL. Charcot-Marie-Tooth disease masquerading as acute demyelinating encephalomyelitis-like illness. Pediatrics 2014;134:e270-e273.
33. Atzori M, Battistella PA, Perini P, et al. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: A single centre prospective study. Mult Scler 2009;15:363-370.
34. Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol 2009;51:480-486.
35. Callen DJ, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009;72:968-973.
36. Verhey LH, Branson HM, Shroff MM, et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: A prospective national cohort study. Lancet Neurol 2011;10:1065-1073.
37. Donmez FY, Aslan H, Coskun M. Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusionweighted imaging. Acta Radiol 2009;50:334-339.
38. Balasubramanya KS, Kovoor JM, Jayakumar PN, et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 2007;49:177-183.
39. Zuccoli G, Panigrahy A, Sreedher G, et al. Vasogenic edema characterizes pediatric acute disseminated encephalomyelitis. Neuroradiology 2014;56:679-684.
40. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22: 1125-1130.
41. Inglese M, Salvi F, Iannucci G, Mancardi GL, Mascalchi M, Filippi M. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2002;23: 267-272.
42. Pavone P, Pettoello-Mantovano M, Le PA, et al. Acute disseminated encephalomyelitis: A long-term prospective study and meta-analysis. Neuropediatrics 2010;41:246-255.
43. Erol I, Ozkale Y, Alkan O, Alehan F. Acute disseminated encephalomyelitis in children and adolescents: A single center experience. Pediatr Neurol 2013;49:266-273.
44. Hung PC, Wang HS, Chou ML, Lin KL, Hsieh MY, Wong AM. Acute disseminated encephalomyelitis in children: A single institution experience of 28 patients. Neuropediatrics 2012;43:64-71.
45. Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004;23: 756-764.
46. Franciotta D, Columba-Cabezas S, Andreoni L, et al. Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol 2008; 200:125-128.
47. Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol 2012;14: 264-275.
48. Waldman AT, Gorman MP, Rensel MR, Austin TE, Hertz DP, Kuntz NL. Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol 2011;26: 675-682.
49. Dale RC, de SC, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;12:2407-2422.
50. Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999;165:56-61.
51. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol 1999;21:583-586.
52. Miyamoto K, Kozu S, Arakawa A, et al. Therapeutic hypothermia with the use of intracranial pressure monitoring for acute disseminated encephalomyelitis with brainstem lesion: A case report. J Child Neurol 2014;29:NP69-NP73.
53. Granget E, Milh M, Pech-Gourg G, et al. Life-saving decompressive craniectomy for acute disseminated encephalomyelitis in a child: A case report. Childs Nerv Syst 2012;28:1121-1124.
54. Tenembaum SN. Acute disseminated encephalomyelitis. Handb Clin Neurol 2013;112:1253-1262.
55. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset. Pediatr Neurol 2004;31:191-197.
56. Suppiej A, Cainelli E, Casara G, Cappellari A, Nosadini M, Sartori S. Long-term neurocognitive outcome and quality of life in pediatric acute disseminated encephalomyelitis. Pediatr Neurol 2014;50: 363-367.